PRIMARY STUDY
β-Caryophyllene attenuates lipopolysaccharide-induced acute lung injury via inhibition of the MAPK signalling pathway
Key Findings: Resulting data revealed that BCP protects against inflammatory responses. The authors posit that BCP is a potentially novel therapeutic compound for the treatment of lipopolysaccharide-induced acute lung injury.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): China
Year of Pub: 2021
Cannabinoids Studied:
Phytocannabinoid Source: Not Applicable
Terpenes Studied: ß-Caryophyllene
Ligands Studied: Anti-inflammatory cytokines, Pro-inflammatory cytokines
Citation: Zhang Y, et al. β-Caryophyllene attenuates lipopolysaccharide-induced acute lung injury via inhibition of the MAPK signalling pathway. J Pharm Pharmacol. 2021; 73:1319-1329. doi: 10.1093/jpp/rgab074
Authors: Zhang Y, Zhang H, Li Y, Wang M, Qian F
